Tampere University, Finland
Mannan-binding lectin is a co-factor in the development of atherosclerosis
Published in Genetics and Environmental Health Week, January 5th, 2005
According to the report from Finland, "Mannan-binding lectin (MBL) is a serum acute-phase protein and a complement component secreted by the liver. Its deficiency caused by point mutations in the MBL gene has recently been associated with severe atherosclerosis. In [our] study, we investigated the effect of MBL variant alleles on coronary artery reactivity, which is an early marker of coronary dysfunction and predicts the development of atherosclerosis and coronary artery disease."
J. Aittoniemi and colleagues of Tampere...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Genetics and Environmental Health Week
More Articles from Genetics and Environmental Health Week
- ALTANA, AG
European marketing for Alvesco to begin - All India Institute Med Science, New Delhi
Drug-related risks higher than sex-related risks in injection drug users - American Society of Hematology
New studies identify advances in sickle cell disease treatment - American Society of Hematology
Thalidomide may be effective in fighting bone marrow cancer, 2 studies show - AstraZeneca
Data presented from early breast cancer treatment trial - Atomic Energy Commission, Fontenay-aux-Roses
Fas and p53 involved in apoptotic response to gamma-irradiation - More from this issue of Genetics and Environmental Health Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
